dr. reddy's labs glp-1 receptor agonist medications With the launch of Obeda®, India's first DCGI-approved semaglutide injection for Type 2 Diabetes, we are excited to support diabetes care in India with high-quality, accessible and affordable treatment. In a head-to-head Dr. Reddy's says API issue
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15


























